Skip to main content

Primary angioplasty

NEW YORK, June 14 (Praxis Press) Rapid reperfusion after acute myocardial infarction (MI) using thrombolytic therapy reduces mortality, but whether time to primary angioplasty is also related to mortality is unclear. Investigators examined 27,080 patients with acute MI associated with ST-segment elevation or left bundle-branch block who were treated with angioplasty (see paper). Cannon and colleagues found that the odds of in-hospital mortality increased from 41% to 62% when the time to primary

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

NEW YORK, June 14 (Praxis Press) Rapid reperfusion after acute myocardial infarction (MI) using thrombolytic therapy reduces mortality, but whether time to primary angioplasty is also related to mortality is unclear. Investigators examined 27,080 patients with acute MI associated with ST-segment elevation or left bundle-branch block who were treated with angioplasty (see paper). Cannon and colleagues found that the odds of in-hospital mortality increased from 41% to 62% when the time to primary angioplasty was more than 2 hours after the patient had arrived at the hospital. Increasing delay from symptom onset to primary angioplasty, however, was not associated with a significant increase in in-hospital mortality. Minimizing the time from patient arrival to primary angioplasty reduces patient mortality.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo